GLP-1 weight loss drugs like Mounjaro and Wegovy are transforming obesity treatment in SA amid rising health concerns and systemic barriers. Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
NEMLC begins a GLP-1 medicines review to assess affordability and potential inclusion in the public health sector for diabetes and obesity Subscription Required You must be a subscriber to access all of this content. View Subscriptions Already a subscriber? Log in...
